if the hypertrophied and inflamed synovium remains unremoved. 7 8 These findings indicate that synovitis is rather a secondary event caused by a preceding lesion in the articular cartilage and subchondral bone. This notion coincides with our previous observation that anti-type II collagen IgG antibody appears in high incidence during the early phase of RA. [9] [10] [11] The major antigenic determinants that are recognised by RA sera were found to reside in the region represented by cyanogen bromide(CNBr) peptide -11 and 8(CB-11,CB-8) of human type II collagen molecule. 10 11 Anti-type II collagen antibody was all negative in sera from patients with gout, osteoarthritis (OA) and non-arthritic diseases. [9] [10] [11] To impart an approach for understanding the pathogenesis of RA, we have performed histological and immunohistochemical studies on the arthritic joints (13 knees and 8 hips) of RA patients (21 women, age 27-68 years, mean 58). Articular cartilage and adjacent subchondral bone samples obtained from RA patients during surgery (synovectomy or prosthetic joint replacement) were macroscopically normal, apart from the bare area, and not invaded by synovial pannus. All of the joints demonstrated diVerent degrees of synovial inflammation. Human osteoarthritic and rheumatoid arthritic articular cartilages were examined for type II collagen degradation using antibodies against CNBr derived peptides of type II collagen. Although histologically, the surface of this cartilage appears smooth and undamaged, immunohistochemical analysis showed less staining for type II collagen and intense staining for CNBr derived peptides of type II collagen in the deep zone matrix than anywhere else (fig 1) . In contrast, the deep zone of articular cartilage from OA patients (10 women, age 42-72 years, mean 65) was stained with antibody against type II collagen. Similar degradation pattern of cartilage matrix in RA was previously shown by Dodge et al. 12 A wholly diVerent mechanism may be the basis of joint destruction in RA and OA. Type II collagen breakdown peptides in the deep zone of rheumatoid arthritic cartilage may become epitopes as we previously pointed out. 10 11 The most striking finding was that there is a considerable formation of islands that invade into the deep zone of articular cartilage through the calcified cartilage from below, where the subchondral bone is located (fig 2) . This pattern was observed in 16 of 21 (76%) samples. These islands are not in contact with the articular margins and contain a significant amount of TRAP positive multinucleated cells. Inflammation was also confirmed in the underlying subchondral bone, and CD68 posi- 
Figure 2 Immunostaining of sample tissues from RA patients (a-d) and MRL/Mp-lpr/lpr mouse (e). The staining for TRAP was performed according to the method of Burstone. 21 Immunostaining was done as described in figure 1, using mouse monoclonal antibody against human CD68 (Dako, Denmark), HLA-DR (Dako, Denmark), and leucocyte T cell (MT1, Bio-science products, Switzerland). (a) Islands (arrows) that invaded into the deep zone of articular cartilage (AC) through the calcified cartilage from the subchondral bone (SB). TRAP positive multinucleated cells (arrowhead); (b) CD68 positive cells; (c) MT-1 positive cells; (d) HLA-DR positive cells in islands and subchondral bone. (e) TRAP positive multinucleated cells (arrows) beneath undamaged AC preceding remarkable inflammation of the synovial membrane (SM). ((a) Original magnification × 13.2, (b) original magnification × 66, (c) to (e) original magnification × 132).
cal changes described above may produce subchondral cysts that are not related to the synovial granulation tissue (fig 3) .
In collagen induced arthritis (CIA) in rodents, 13 antibody against autologous type II collagen was shown to be critically involved in the pathogenesis of CIA, 14 and L3T4 + T cells are required for the immunity against type II collagen. 15 MRL/Mp-1pr/1pr autoimmune mouse is known to develop a spontaneous destructive arthropathy sharing many features with RA. 16 Tarkowski et al 17 demonstrated circulating antibody against type II collagen in the mouse and suggested that induction of anti-type II collagen antibody is triggered by articular cartilage destruction and subsequent release of type II collagen. Interestingly we have observed pathological changes identical to those in human subchondral bone with RA preceding remarkable inflammation of synovial membrane (fig 2) . Thus, by continuously concentrating on the study of synovitis, the actual key event in the aetiology of RA may be overlooked. We propose the possibility that the initiation of the rheumatoid process is triggered by the autoimmune reaction involving type II collagen in the articular cartilage as a consequence of an unknown aetiological agent. Synovitis and other extra-articular features may be induced secondary to the immune complex formation in the subchondral area. In fact, a previous study showed that insoluble IgG antibodyantigen complexes are capable of initiating the release of inflammatory mediators from isolated macrophages in vivo. 18 It seems possible that synovial inflammation, and all that accompanies it, may play a pivotal part in amplifying the earlier eVects of an autoimmune reaction against type II collagen of articular cartilage. Presently, we do not possess the scientific evidence that excludes the possibility that very small changes in the synovial membrane are triggering the RA onset. However, we cannot exclude the possibility that osteoclast, macrophage and immunocyte infiltration as well as articular cartilage degradation are triggers. If the proposed sequence of events is proved, it will be ideal to direct our focus to medical treatment that suppress the invasion of osteoclastic cells and immunocytes in the subchondral bone rather than the inflammation of the synovial membrane. 
